With what analysts are calling "strong" data, Amgen plans to file a regulatory submission for Uplizna, currently approved for ...

Generalised Myasthenia Gravis-This occurs when weakness occurs in multiple groups of muscles. Ocular Myasthenia Gravis-This occurs when the disease-related muscle weakness is restricted to the ...

The only ocular movements possible were 5 to 10 ... and failed to exert any extrathyroidal influence on the myasthenia gravis. From the hundred and twentieth to the hundred and seventieth ...

Myasthenia gravis is a neuromuscular junction disorder with a hallmark of progressive muscle weakness and frequent ...

Findings from MINT will be presented at the American Academy of Neurology Annual Meeting on April 8, 2025, in San Diego.

Decreased AChR-Ab titers correlated with improved myasthenia gravis symptoms, especially in ADL scores, within the first 3 months of treatment. The study found no baseline correlation between AChR ...

Myasthenia gravis is a chronic autoimmune disorder that causes muscle ... The most dramatic response is usually seen in patients with ocular difficulties. Patients with complete closure of the eyelids ...

Some people have double vision. Eye weakness is often the first sign of myasthenia. Ocular myasthenia gravis may evolve into the generalized form for nearly half of all people diagnosed with this ...

Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular junction ...